MacuCLEAR, inc. secures funds to advance MC-1101 trial PBR Staff Writer – Pharmaceutical business review

Home/In the News/MacuCLEAR, inc. secures funds to advance MC-1101 trial PBR Staff Writer – Pharmaceutical business review

MacuCLEAR, inc. secures funds to advance MC-1101 trial PBR Staff Writer – Pharmaceutical business review

MacuCLEAR, a developer of novel solutions for vascular disorders of the eye, has received over $1m in funds from current investors to complete Phase 3a human efficacy trial of its lead product, MC-1101.

Read the Full Article
2017-05-23T18:33:43+00:00 January 4, 2012|Categories: In the News|0 Comments